| Product Code: ETC6750025 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Partial Androgen Insensitivity Syndrome Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Partial Androgen Insensitivity Syndrome Market Revenues & Volume, 2021 & 2031F |
3.3 China Partial Androgen Insensitivity Syndrome Market - Industry Life Cycle |
3.4 China Partial Androgen Insensitivity Syndrome Market - Porter's Five Forces |
3.5 China Partial Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 China Partial Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.7 China Partial Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 China Partial Androgen Insensitivity Syndrome Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Partial Androgen Insensitivity Syndrome Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of partial androgen insensitivity syndrome (PAIS) in China. |
4.2.2 Advancements in medical technology leading to improved treatment options for PAIS patients. |
4.2.3 Government initiatives and healthcare policies supporting better access to care for individuals with PAIS. |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals with expertise in managing PAIS. |
4.3.2 High cost of treatment and medications for PAIS patients. |
4.3.3 Social stigma and lack of societal acceptance leading to delayed diagnosis and treatment for individuals with PAIS. |
5 China Partial Androgen Insensitivity Syndrome Market Trends |
6 China Partial Androgen Insensitivity Syndrome Market, By Types |
6.1 China Partial Androgen Insensitivity Syndrome Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 China Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 China Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Surgery, 2021- 2031F |
6.1.4 China Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Estrogen or Testosterone Therapy, 2021- 2031F |
6.1.5 China Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Partial Androgen Insensitivity Syndrome Market, By Mode of Administration |
6.2.1 Overview and Analysis |
6.2.2 China Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Injectables, 2021- 2031F |
6.2.3 China Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.4 China Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Partial Androgen Insensitivity Syndrome Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 China Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 China Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 China Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.4 China Partial Androgen Insensitivity Syndrome Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 China Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 China Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 China Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 China Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
7 China Partial Androgen Insensitivity Syndrome Market Import-Export Trade Statistics |
7.1 China Partial Androgen Insensitivity Syndrome Market Export to Major Countries |
7.2 China Partial Androgen Insensitivity Syndrome Market Imports from Major Countries |
8 China Partial Androgen Insensitivity Syndrome Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis for PAIS patients in China. |
8.2 Number of healthcare facilities offering specialized care for PAIS across different regions in China. |
8.3 Patient satisfaction with the quality of care and support received for managing PAIS. |
8.4 Percentage of PAIS patients receiving appropriate and timely treatment according to established guidelines. |
8.5 Rate of adherence to treatment plans among PAIS patients in China. |
9 China Partial Androgen Insensitivity Syndrome Market - Opportunity Assessment |
9.1 China Partial Androgen Insensitivity Syndrome Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 China Partial Androgen Insensitivity Syndrome Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.3 China Partial Androgen Insensitivity Syndrome Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 China Partial Androgen Insensitivity Syndrome Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Partial Androgen Insensitivity Syndrome Market - Competitive Landscape |
10.1 China Partial Androgen Insensitivity Syndrome Market Revenue Share, By Companies, 2024 |
10.2 China Partial Androgen Insensitivity Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here